Table I.
Primer sequences used in the present study.
Primer | Sequence |
---|---|
miRNA-146a mimics | |
Forward | 5′-UGAGAACUGAAUUCCAUGGGUU-3′ |
Reverse | 5′-CCCAUGGAAUUCAGUUCUCAUU-3′ |
miRNA-146a inhibitor | 5′-AACCCAUGGAAUUCAGUUCUCA-3′ |
JNK2 primers | |
Forward | 5′-CTGCGTCACCCATACATC-3′ |
Reverse | 5′-TGGCGTTGCTACTTACTGC-3′ |
p53 primers | |
Forward | 5′-TGCGTGTGGAGTATTTGGATG-3′ |
Reverse | 5′-TGGTACAGTCAGAGCCAACCAG-3′ |
Bcl-2 primers | |
Forward | 5′-CTGGTGGACAACATCGCTCTG-3′ |
Reverse | 5′-GGTCTGCTGACCTCACTTGTG-3′ |
JNK2, Jun kinase 2; Bcl-2, B cell lymphoma 2; F, forward; R, reverse.